Sartorius Welcomes Dr. Florian Funck as CFO and Executive Board Member

  Dr. Funck brings a wealth of experience and expertise to his new role. Having studied business administration at the prestigious University of M&uu...

April 03, 2024 | Wednesday | News
Nurturing Sustainability in Life Sciences: A Dialogue with Ryan Walker, Sustainability Programme Leader at Cytiva

  Cytiva shines as a model of sustainable principles in the dynamic field of life sciences, where pioneering innovation intersects with societal resp...

March 26, 2024 | Tuesday | Interaction
Positive CHMP Opinions for Bempedoic Acid and Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet

    “We are thrilled with the positive CHMP opinion, which reflects the significant cardiovascular risk reduction benefit that the bemped...

March 25, 2024 | Monday | News
BIO Sets New Strategic Direction on National Security Under Leadership of CEO John F. Crowley

    Why Biotech is a National Security Imperative John F. Crowley, stepping into his role as BIO's President and CEO, ...

March 15, 2024 | Friday | Reports
Merck's CEO Belén Garijo Champions Resilience and Growth Amidst 2023's Market Challenges, Sets Strategic Path for Sustainable Success

Financial results of fiscal 2023 Net sales decrease organically by 1.6% to € 21.0 billion EBITDA pre down organically by 9.0% to € ...

March 07, 2024 | Thursday | News
ICON CEO, Dr. Steve Cutler, Highlights Strong Performance and Affirms 2024 Financial Guidance

ICON plc (NASDAQ:ICLR), a global leader in healthcare intelligence and clinical research,  announced its financial results for the fourth quarter and ...

February 22, 2024 | Thursday | Company results
Bio-Rad's CEO, Norman Schwartz, Anticipates Sector Rebound in 2024 Amid Fourth Quarter Challenges

Bio-Rad Laboratories Inc. reports a 6.7% decrease in fourth-quarter net sales compared to 2022, largely attributed to ongoing weakness in biopharma markets...

February 16, 2024 | Friday | Company results
CEO Ari Bousbib Commends IQVIA's Resilience Amidst Challenging 2023 Landscape

  -IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services ...

February 15, 2024 | Thursday | Company results
GDMC Charts a New Course in Genetic Therapy Innovation with Strategic Series A Investment

In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...

February 14, 2024 | Wednesday | Interview
Catalent CEO Alessandro Maselli Celebrates Q2 Triumphs, Forges Transformative Alliance with Novo Holdings to Supercharge Growth

Q2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency(1), compared to Q2'23. Q2'24 net revenue, excluding COVID...

February 12, 2024 | Monday | Company results
Illumina Surpasses Expectations in Q4, Driven by NovaSeq X Sales, CEO Jacob Thaysen Reports

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company")  disclosed its financial performance for the fourth quarter and fiscal year 2023, includin...

February 09, 2024 | Friday | Company results
CEO Pascal Soriot Highlights AstraZeneca's Strong Financial Performance and Scientific Progress in 25th Anniversary Year

Key Points: AstraZeneca announces robust financial performance for the full year and fourth quarter of 2023, marked by strong revenue growth and s...

February 08, 2024 | Thursday | Company results
Bristol Myers Squibb CEO Christopher Boerner Highlights Strong Q4 Performance and Strategic Actions for Sustainable Growth in 2024

Bristol Myers Squibb (NYSE: BMY) announced its financial results for the fourth quarter and full year of 2023, demonstrating robust performance, pipeline a...

February 05, 2024 | Monday | Company results
OmniActive Health Technologies Welcomes Amit Chopra as President and CEO

Amit Chopra, a seasoned professional with a proven track record in leadership, commercial strategies, manufacturing, mergers and acquisitions, and innovati...

February 02, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in